ANGEL WENGER: Open Payments
NPI 1811267909 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,536 in 157 payments from 20 companies in 2025. Trend: 2023 $1,950 · 2024 $3,157 · 2025 $3,536
Food & beverage: $3,493Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $465 |
| Arcutis Biotherapeutics, Inc. | 17 | $392 |
| LEO Pharma Inc. | 19 | $321 |
| UCB, Inc. | 7 | $300 |
| Janssen Biotech, Inc. | 12 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $253 |
| Galderma Laboratories, L.P. | 13 | $235 |
| Organon LLC | 16 | $232 |
| GENZYME CORPORATION | 6 | $200 |
| Incyte Corporation | 9 | $200 |
Products named: Zoryve, Bimzelx, DUPIXENT, ADBRY, TREMFYA, VTAMA, SKYRIZI, OPZELURA.
Industry payments across NV — which companies pay providers there.
